相关实验视频

Updated: Sep 13, 2025

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

rhPTH(1-84) 治疗缺甲状腺症:对患者报告结果的随机研究

Maria Luisa Brandi¹, Tamara Vokes², Natasha M Appelman-Dijkstra³

¹Fondazione Italiana Ricerca Sulle Malattie Dell'Osso, Fondazione Italiana Ricerca Sulle Malattie Dell'Osso, 50229 Florence, Italy.

European journal of endocrinology

|July 25, 2025

概括

与安慰剂相比,复合性人类副甲状腺激素 (1-84) 显著改善了慢性副甲状腺症患者的生活质量,并减少了症状. 这项研究强调了rhPTH ((1-84) 作为症状性cHypoPT的有效治疗选择.

科学领域:

内分泌学在内分泌学.
临床药理学临床药理学

背景情况:

慢性偏偏甲状腺症 (cHypoPT) 显著影响患者的与健康相关的生活质量 (HRQoL).
传统的维生素D和治疗可能无法完全解决cHypoPT的症状负担.

研究的目的:

评估复合人副甲状腺激素 (1-84) [rhPTH(1-84) ]在改善症状cHypoPT患者的HRQoL方面的疗效.
为了比较 rhPTH ((1-84) 加常规疗法与安慰剂加常规疗法.

主要方法:

一项随机,双盲,安慰剂控制的3b-4期研究 (NCT03324880) 涉及93名症状cHypoPT.患者.
患者在26周内接受皮下rhPTH ((1-84) (25-100微克/天) 或安慰剂.
主要终点:低甲状腺功能障碍症症状日记 (HypoPT-SD) 症状分级得分的变化. 二级终点:FACIT-Fatigue和SF-36v2 PCS得分的变化.

主要成果:

与安慰剂 (P = .003) 相比,rhPTH(1-84) 治疗导致HypoPT-SD症状得分的明显改善.
在rhPTH(1-84) 组中,FACIT-Fatigue和SF-36v2 PCS得分的显著改善也被观察到.
rhPTH ((1-84) 的安全概况与之前的研究一致,没有发现新的安全问题.

结论:

rhPTH(1-84),当添加到常规疗法时,有效地减少症状负担,并提高症状cHypoPT患者的HRQoL.
rhPTH ((1-84) 是一种有价值的治疗选择,用于治疗症状性慢性低甲状腺瘤.

关键词:

人类副甲状腺激素治疗治疗甲状腺过敏症 (hypoparathyroidism) 是一种严重的疾病.患者报告的结果.rhPTH ((1-84)) 的使用情况.

更多相关视频

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

相关概念视频

The Parathyroid Glands

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...